NCT04156750View on ClinicalTrials.gov

A Study of LY3556050 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

August 3, 2020

Study Completion Date

August 3, 2020

Conditions
Healthy
Interventions
DRUG

LY3556050

Administered orally.

DRUG

Placebo

Administered orally.

DRUG

Iohexol

Administered IV.

DRUG

Metformin

Administered orally.

Trial Locations (1)

75247

Covance, Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04156750 - A Study of LY3556050 in Healthy Participants | Biotech Hunter | Biotech Hunter